IP Library Granted Patent US 12,280,019
Granted Patent B2
US 12,280,019 · App. 18/607,433 · Granted Apr 22, 2025

Anti-aging therapy for humans and other mammals

Inventor: Richard Postrel (Miami Beach, FL)
A61K31/05A23K20/111A23K20/121A23K20/184A61K31/085A61K31/192A61K31/352A61K31/566
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,280,019
App. No.
18/607,433
Granted
Apr 22, 2025
Kind
B2
Abstract

The present invention discloses a system and method for preparing and delivering various precursor compositions as a replacement therapy for testosterone and other hormone deficiencies that naturally occur with aging in humans and other mammals. Precursor compositions are selected and designed for the purpose of formulating non-toxic therapeutic hormone supplement for oral consumption. The invention features low dose continuous supplementation to be incorporated with daily meals. The process of the present invention delivers an orally ingested substance, e.g., a food, supplement, etc., that contains an anti-aging formulation comprising a hormone precursor (prohormone) that is absorbed by the digestive system and secreted into the bloodstream with a second substance to facilitate its ingestion, absorption and delivery to the body's tissues.

Claims (21)

1. A composition comprising >1.0 mg of an androgenic prohormone and >0.5 mg of a compound that binds and stimulates a mammalian endocannabinoid receptor.

2. The composition of claim 1 said prohormone is selected from the group consisting of: DHEA, 7-keto DHEA and DHEA-S.

3. The composition of claim 1 wherein said endogenous endocannabinoid receptor is selected from the group consisting of: CB1, CB2, TRPV1, TRPV2, TRPV3, TRPV4, TRPA1, TRPM8, GPR18, GPR119, GPR55, GPR118 and analogues thereto.

4. The composition of claim 1 wherein said compound that binds and stimulates a mammalian endocannabinoid receptor comprises a member of a class selected from the group consisting of: cannabigerol class, cannabichromene class, cannabicyclol class, Δ 8 -tetrahydrocannabinol class, cannabieson class, cannabinol and cannabinodiol class, cannabitriol class, and miscellaneous class.

5. The composition of claim 4 wherein said compound that binds and stimulates a mammalian endocannabinoid receptor comprises a member of the cannabinol and cannabinodiol class.

6. The composition of claim 4 wherein said compound that binds and stimulates a mammalian endocannabinoid receptor comprises a member of the Cannabichromene class.

7. The composition of claim 6 wherein said compound that binds and stimulates a mammalian endocannabinoid receptor comprises a compound selected from the group consisting of: cannabidiolic acid (CBDA), cannabidiol (CBD), cannabidiol monomethylether (CBDM), cannabidiol C4 (CBD-C4), and cannabidivarinic acid (CBDVA).

8. The composition of claim 1 further comprising an oil selected from the group consisting of: vegetable, rapeseed/canola, soy, corn, peppermint, lavender, sandalwood, bergamot, rose, chamomile, ylang-ylang, tea tree, myrcene/hops, jasmine, and lemon.

9. The composition of claim 1 further comprising nutmeg or nutmeg extract.

10. The composition of claim 1 formulated as an oral preparation selected from the group consisting of: a food, a toothpaste, a spritz, a snack, a food supplement, a reward, a spray, an ampule, a chewable edible, a supplemented rawhide, a vitamin D supplement, and a chew toy.

11. The composition of claim 10 wherein ingesting or feeding said composition to an animal results in increased activity.

12. The composition of claim 1 formulated as a feed supplement, said supplement in a format selected from the group consisting of: a gel, a powder, a liquid, a grating, a strip, an ampule, a tablet, and a capsule.

13. The composition of claim 1 comprising an outer coating that crunches when crushed to release a soft encapsulated portion.

14. The composition of claim 13 wherein said encapsulated portion comprises a compound that binds and stimulates a mammalian endocannabinoid receptor.

15. The composition of claim 13 wherein said encapsulated portion comprises an androgenic prohormone.

16. The composition of claim 13 wherein outer coating that crunches comprises a compound that binds and stimulates a mammalian endocannabinoid receptor.

17. The composition of claim 13 wherein outer coating that crunches comprises an androgenic prohormone.

18. The composition of claim 13 wherein outer coating that crunches comprises an androgenic prohormone.

19. The composition of claim 1 further comprising an outer coating that serves as a marker or label identifying the composition.

20. A method for providing an anti-aging composition to a canine, said method comprising delivering to a canine the composition of claim 1 .

21. A method of making the composition of claim 1 comprising spraying a mist comprising said compound that binds and stimulates a mammalian endocannabinoid receptor onto a food or food supplement comprising said androgenic prohormone.

Continuity (11)
Continuation In Part 18236397 · Aug 21, 2023
Continuation In Part PCTUS2022017142 · Feb 21, 2022
Continuation 17227320 · Apr 11, 2021
Continuation 17227320 · Apr 11, 2021
Continuation In Part 15952226 · Apr 12, 2018
Continuation In Part 15950230 · Apr 11, 2018
Provisional Application 63151073 · Feb 19, 2021
Provisional Application 63015073 · Apr 24, 2020
Provisional Application 62537027 · Jul 26, 2017
Provisional Application 62537031 · Jul 26, 2017
Related Publication 20240216295A1 · Jul 4, 2024
References Cited (6)
US 8221809B2 · Subramanian · 2012 [cited by examiner]
US 9480689B1 · McGlone · 2016 [cited by examiner]
US 20180071314A1 · Dunlop · 2018 [cited by examiner]
US 20240043473A1 · Wood · 2024 [cited by examiner]
WO WO2020239784A1 · 2020 [cited by examiner]
Genetically modified microbial host cell (Year: 2020). [cited by examiner]